CHARLES TOWN, W.Va., April 2, 2008 /PRNewswire-FirstCall/ -- ReBuilder Medical Technologies, Inc. (Pink Sheets: RBRM), developers of state of the art electronic devices for diabetic peripheral neuropathy, Molluscum Contagiosum, and MRSA; today reported March sales numbers exceeding all previous months.
(Logo: http://www.newscom.com/cgi-bin/prnh/20061128/REBUILDERLOGO )
"Our March sales topped $410,000; continuing the company's growth curve. We expect to continue that growth during the rest of this year," says David B. Phillips, Ph.D., President of ReBuilder Medical Technology, Inc. (RBRM) "Many investors have begun to appreciate that even in this recession, we are a sound company, with no debt to service, manufacturing our own medical products with American parts and American labor, and with a large overseas market. We have been operating in the same facility with the same management since 2003."
For more information visit: http://www.rebuildermedical.com and http://www.molluscum.com.
Safe Harbor: This letter contains certain forward-looking statements
within the meaning of Section 27A of the Securities Act of 1933, as amended
and Section 21E of the Securities Exchange Act of 1934, as amended, which
are intended to be covered by the safe harbors created thereby. Investors
are cautioned that all forward-looking statements involve risks and
uncertainty, including without limitation, the ability of the Company to
successfully implement its turnaround strategy, changes in costs of raw
materials, labor, and employee benefits, as well as general market
conditions, competition and pricing. Although the Company believes that the
assumptions underlying the forward-looking statements contained herein are
reasonable, any of the assumption
'/>"/>
| SOURCE ReBuilder Medical Technologies, Inc. Copyright©2008 PR Newswire. All rights reserved |